Boston Scientific Corp.
| New York Stock Exchange: BSX
Boston Scientific Corp. develops, manufactures and markets medical devices that are used in a broad range of interventional medical specialties. The company's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. It operates its business through four geographic reportable segments: United States; EMEA, consisting of Europe, the Middle East and Africa; Japan and Inter-Continental, consisting of Asia Pacific and the Americas operating segments. The reportable segments represent an aggregate of all operating divisions within each segment. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Natick, MA.